Patients with brain metastasis showed a lower proportion of recovery from irAEs; however, this difference did not reach statistical significance (Supplementary Fig. 3 ).
← all excerpts
Organ-metastatic landscape delineates overall and site-specific immune-related adverse events of PD-L1 blockade in advanced NSCLC.
1
—
—